Tag: biosimilars
Why Some Brand-Name Drugs Have No Generic Alternatives: Patents, Complexity, and Market Tactics
Explore why some brand-name drugs lack generic alternatives due to patent thickets, complex formulations, and biosimilar regulations. Learn how these factors impact drug pricing and patient access.